Walleye Capital’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-113,900
Closed -$327K 4508
2025
Q4
$327K Buy
+113,900
New +$316K ﹤0.01% 3241
2025
Q3
Sell
-147,960
Closed -$577K 4628
2025
Q2
$577K Buy
147,960
+114,894
+347% +$362K ﹤0.01% 2513
2025
Q1
$95.6K Sell
33,066
-12,238
-27% -$49.7K ﹤0.01% 3645
2024
Q4
$186K Buy
45,304
+797
+2% +$3.48K ﹤0.01% 3813
2024
Q3
$199K Buy
44,507
+13,412
+43% +$62.9K ﹤0.01% 4009
2024
Q2
$170K Buy
+31,095
New +$196K ﹤0.01% 4420
2023
Q4
Sell
-13,869
Closed -$111K 5053
2023
Q3
$111K Buy
13,869
+3,242
+31% +$32.6K ﹤0.01% 3897
2023
Q2
$117K Buy
+10,627
New +$109K ﹤0.01% 3369

Other funds holding DH

Walleye Capital's DH Position: Q1 2026 in Review

Walleye Capital sold out of Definitive Healthcare (DH) in Q1 2026, closing a stake of 113,900 shares — an estimated $327K sold.

Walleye Capital first reported a position in DH in Q2 2023 and held it in 8 quarters. The position peaked at $577K in Q2 2025. 119 funds tracked by Wall St. Rank hold DH as of Q1 2026.

  • Walleye Capital reported no remaining Definitive Healthcare position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 113,900 Definitive Healthcare shares in Q1 2026, an estimated $327K.
  • Walleye Capital first reported a position in Definitive Healthcare in Q2 2023 and held it in 8 quarters.
  • Walleye Capital's Definitive Healthcare position peaked at $577K in Q2 2025.
  • 119 funds tracked by Wall St. Rank held Definitive Healthcare as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.